Search filters

List of works by Marcus Schmitt-Egenolf

Anti-TNF treatment during pregnancy and birth outcomes: A population-based study from Denmark, Finland, and Sweden

scientific article published on 04 February 2020

Association between interleukin-1 receptor antagonist (IL-1ra) gene polymorphism and early and late-onset psoriasis

scientific article published in January 1997

Association scan of the novel psoriasis susceptibility region on chromosome 19: evidence for both susceptible and protective loci

article

Challenges for synthesising data in a network of registries for systemic psoriasis therapies

scientific article

Complete skin clearance and Psoriasis Area and Severity Index response rates in clinical practice: predictors, health-related quality of life improvements and implications for treatment goals

scientific article published on 16 October 2019

Complete skin clearance and beyond

scientific article published on 08 October 2020

Coping styles in decision-making among men and women diagnosed with malignant melanoma ⬇️

scientific article published on January 16, 2013

Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI).

scientific article

EDAR mutation in autosomal dominant hypohidrotic ectodermal dysplasia in two Swedish families

scientific article

EDAR-induced hypohidrotic ectodermal dysplasia: a clinical study on signs and symptoms in individuals with a heterozygous c.1072C > T mutation

scientific article

Evaluating equality in psoriasis healthcare: a cohort study of the impact of age on prescription of biologics.

scientific article

Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study.

scientific article

Hair shaft structures in EDAR induced ectodermal dysplasia.

scientific article published on 4 September 2015

Health-care delay in malignant melanoma: various pathways to diagnosis and treatment

scientific article published on 05 January 2014

Health-related quality of life in patients with melanoma - characterization of a Swedish cohort

scientific article published on 25 October 2019

Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.

scientific article published on 16 February 2016

How is disease severity associated with quality of life in psoriasis patients? Evidence from a longitudinal population-based study in Sweden

scientific article

Malignant melanoma: gender patterns in care seeking for suspect marks

scientific article published on 21 July 2011

Oligonucleotide typing reveals association of type I psoriasis with the HLA-DRB1*0701/2, -DQA1*0201, -DQB1*0303 extended haplotype

scientific article

Paediatric infections in the first 3 years of life after maternal anti-TNF treatment during pregnancy

scientific article published on 24 July 2020

Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement

scientific article published on 27 September 2016

Physical activity and lifestyle improvement in the management of psoriasis.

scientific article

Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals

scientific article published on 01 April 1994

Promoter polymorphism at -238 of the tumor necrosis factor alpha gene is not associated with early onset psoriasis when tested by the transmission disequilibrium test

scientific article published on 01 April 1999

PsoReg--the Swedish registry for systemic psoriasis treatment. The registry's design and objectives

scientific article published on 01 January 2007

Psoriasis therapy in real life: the need for registries

scientific article published on 01 January 2006

Real-world outcome analysis of continuously and intermittently treated patients with moderate to severe psoriasis after switching to a biologic agent.

scientific article published on 20 February 2015

Real-world outcomes in 2646 psoriasis patients: one in five has PASI ≥10 and/or DLQI ≥10 under ongoing systemic therapy

scientific article

Regional Differences in the Prescription of Biologics for Psoriasis in Sweden: A Register-Based Study of 4168 Patients

scientific article published on 17 January 2017

Register-Based Evaluation of Relative Effectiveness of New Therapies: Biologics Versus Conventional Agents in Treatment of Psoriasis in Sweden.

scientific article published on December 2015

Resource use in patients with psoriasis after the introduction of biologics in Sweden

scientific article published on 01 February 2015

Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients.

scientific article published on 24 March 2017

Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines

scientific article published on 01 September 1999

Sustained PASI, DLQI and EQ-5D response of biological treatment in psoriasis: 10 years of real-world data in the Swedish National Psoriasis Register.

scientific article

Switch to biological agent in psoriasis significantly improved clinical and patient-reported outcomes in real-world practice.

scientific article published in January 2012

Switching biologicals: switching TNFalpha antagonists in psoriasis treatment

scientific article published on 29 January 2008

The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men.

scientific article

Type I and type II psoriasis show a similar usage of T-cell receptor variable regions

scientific article published on 01 December 1991

What can we learn from 'dropouts' in clinical trials?

scientific article published in February 2018

[Register studies measure the effectiveness of drugs in clinical practice. The example PsoReg - redistribution of systemic treatment can increase the efficiency]

scientific article published in June 2014

Paulina is supported by:

About Paulina

Help